BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21550372)

  • 1. Production and characterization of HCV particles from serum-free culture.
    Akazawa D; Morikawa K; Omi N; Takahashi H; Nakamura N; Mochizuki H; Date T; Ishii K; Suzuki T; Wakita T
    Vaccine; 2011 Jun; 29(29-30):4821-8. PubMed ID: 21550372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
    Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
    J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
    Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication.
    Abe K; Ikeda M; Ariumi Y; Dansako H; Kato N
    Virus Res; 2007 May; 125(2):162-8. PubMed ID: 17267063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes.
    Ndongo-Thiam N; Berthillon P; Errazuriz E; Bordes I; De Sequeira S; Trépo C; Petit MA
    Hepatology; 2011 Aug; 54(2):406-17. PubMed ID: 21520209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of infectious hepatitis C virus from liver-derived cell lines.
    Akazawa D; Date T; Morikawa K; Murayama A; Omi N; Takahashi H; Nakamura N; Ishii K; Suzuki T; Mizokami M; Mochizuki H; Wakita T
    Biochem Biophys Res Commun; 2008 Dec; 377(3):747-51. PubMed ID: 18951878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of JFH-1 strain and development of an HCV infection system.
    Wakita T
    Methods Mol Biol; 2009; 510():305-27. PubMed ID: 19009271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    Cheng JC; Yeh YJ; Pai LM; Chang ML; Yeh CT
    J Med Virol; 2009 Sep; 81(9):1560-8. PubMed ID: 19626614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.
    Murakami K; Ishii K; Ishihara Y; Yoshizaki S; Tanaka K; Gotoh Y; Aizaki H; Kohara M; Yoshioka H; Mori Y; Manabe N; Shoji I; Sata T; Bartenschlager R; Matsuura Y; Miyamura T; Suzuki T
    Virology; 2006 Aug; 351(2):381-92. PubMed ID: 16678876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological properties of purified recombinant HCV particles with an epitope-tagged envelope.
    Takahashi H; Akazawa D; Kato T; Date T; Shirakura M; Nakamura N; Mochizuki H; Tanaka-Kaneko K; Sata T; Tanaka Y; Mizokami M; Suzuki T; Wakita T
    Biochem Biophys Res Commun; 2010 May; 395(4):565-71. PubMed ID: 20399750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.
    Lázaro CA; Chang M; Tang W; Campbell J; Sullivan DG; Gretch DR; Corey L; Coombs RW; Fausto N
    Am J Pathol; 2007 Feb; 170(2):478-89. PubMed ID: 17255316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of infectious hepatitis C virus of various genotypes in cell cultures.
    Kato T; Matsumura T; Heller T; Saito S; Sapp RK; Murthy K; Wakita T; Liang TJ
    J Virol; 2007 May; 81(9):4405-11. PubMed ID: 17301131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
    Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
    Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins.
    Ishii K; Murakami K; Hmwe SS; Zhang B; Li J; Shirakura M; Morikawa K; Suzuki R; Miyamura T; Wakita T; Suzuki T
    Biochem Biophys Res Commun; 2008 Jul; 371(3):446-50. PubMed ID: 18445476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles.
    Morikawa K; Zhao Z; Date T; Miyamoto M; Murayama A; Akazawa D; Tanabe J; Sone S; Wakita T
    J Med Virol; 2007 Jun; 79(6):714-23. PubMed ID: 17457918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.